MedPath

The effect of glucoherb and metformin on glycemic indixes in prediabetics patients

Phase 3
Conditions
diabetes mellitus.
With other specified complications
E10-E14
Registration Number
IRCT20190125042486N2
Lead Sponsor
Shahre-kord University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
72
Inclusion Criteria

They do not consume tobacco.
They do not consume alcohol.
Patients who do not take anti-diabetes and insulin medications.
Patients who are not pregnant or breast-feeding.
In the recent 3 months, multivitamin, antioxide and Omega 3 have not received.
Patients who have not kidney, liver, thyroid and parathyroid, gastrointestinal and heart disease and cancer.
Medicines like corticosteroids that have an effect on blood glucose are not consumed
They would like to participate in the project.
Patients who are recognized with prediabetes symptoms.

Exclusion Criteria

Patients cancel continuing the study.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Glycemic indixes. Timepoint: at the end of 12th week. Method of measurement: The checklist contained the name and characteristics of the patients together with the treatment group. Checklists of FBS, BS2PP, HBA1C.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath